Brief: Clene Reports New Data From The Visionary-MS Phase 2 Study In Multiple Sclerosis Demonstrating Cnm-Au8® Treatment Improved Brain Neuronal Structural Integrity

Clene

13/02/2023 12:28

Feb 13 (Reuters) - Clene Inc.  CLNN.O :
    * CLENE REPORTS NEW DATA FROM THE VISIONARY-MS PHASE 2 STUDY
IN
MULTIPLE SCLEROSIS DEMONSTRATING CNM-AU8® TREATMENT IMPROVED
BRAIN NEURONAL STRUCTURAL INTEGRITY
    * CLENE INC. - MRI RESULTS SHOWED IMPROVED BRAIN NEURONAL
STRUCTURAL INTEGRITY, INDEPENDENT OF AN IMMUNOMODULATORY EFFECT
    * CLENE INC. - MRI RESULTS CONSISTENTLY FAVOR CNM-AU8
IMPROVEMENT
OF NEURONAL INTEGRITY AND MYELIN IMPROVEMENT, SHOWING DECREASED
BRAIN DETERIORATION
    * CLENE INC. - MRI RESULTS REINFORCE CLINICAL NEUROLOGICAL
IMPROVEMENTS PREVIOUSLY REPORTED
    * CLENE INC. - BRAIN IMPROVEMENTS IN STABLE MS PATIENTS ON
BACKGROUND THERAPY ARE UNPRECEDENTED

Source text for Eikon:  ID:nGNX1FBxN0 
Further company coverage:  CLNN.O 
 ((Reuters.Briefs@thomsonreuters.com;;))